Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 80% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.
Compare CURE with another fund →IMVT
IMMUNOVANT INC
Health Care · United States · 0.69% of CURE on average
Contributed −$7 per $10k to CURE over the last week.
Loading…
Explained moves, and what each did to CURE
Nothing flagged in this range.
About CURE
- TypeSector & thematic
- IssuerGlobal X
- Size$39.6m
- Cost0.45% a year
- Holdings157
- Top sectorHealth Care 80%
- Top 2 holdings4%
CURE fell 4.0% over the last week. On $10,000, that's −$403. TWST was the biggest drag at −$42; PCVX helped most at +$18.
What moved it
Gain or loss per $10k invested
- TWSTTwist−$42
- PCVXVaxcyte+$18
- SYRESpyre−$17
- CRSPCrispr−$14
- RVMDRevolution−$13
- UTHRUnited Thera.−$11
- TVTXTravere−$11
- PRAXPraxis−$10
- IOVAIovance−$10
- ORKAOruka−$10
- VKTXViking−$9
- INSMInsmed−$9
- MRNAModerna+$9
- CELCCelcuity−$9
- DNTHDianthus−$8
- BMRNBiomarin−$8
- NTRANatera−$8
- CGONCG Oncology−$8
- ERASErasca+$8
- TNGXTango−$7
- IBRXImmunitybio+$7
- ABBVAbbVie+$7
- ARWRArrowhead−$7
- IMVTImmunovant−$7
- SRRKScholar Rock−$7
- MDGLMadrigal−$6
- INCYIncyte−$5
- HALOHalozyme+$4
- PTCTPTC Thera.−$3
- BIIBBiogen−$3
- EXELExelixis+$3
- ALKSAlkermes−$1
- VRTXVertex Pharma−$1
- KRYSKrystal+$1
- REGNRegeneron+$1
- PTGXProtagonist+$1
- TGTXTg Thera.−$1
- NBIXNeurocrine+$0
- GILDGilead−$0
- GRALGrail+$0
- AMGNAmgen+$0
- UnattributedFX, hedging, fees, timing−$150
- CompoundingDaily returns multiply, they do not add+$3
- Fund return−$403
- Other 3 kinds of news−$3
- Other 1 kind of news−$5
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.